278 related articles for article (PubMed ID: 32851039)
21. Basal Level p53 Suppresses Antiviral Immunity against Foot-and-Mouth Disease Virus.
Zhang T; Chen H; Liu X; Qi L; Gao X; Wang K; Yao K; Zhang J; Sun Y; Zhang Y; Wu R
Viruses; 2019 Aug; 11(8):. PubMed ID: 31394868
[TBL] [Abstract][Full Text] [Related]
22. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells.
Zhang ZD; Hutching G; Kitching P; Alexandersen S
Arch Virol; 2002 Nov; 147(11):2157-67. PubMed ID: 12417950
[TBL] [Abstract][Full Text] [Related]
23. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-λ1 pathway.
Wang D; Fang L; Liu L; Zhong H; Chen Q; Luo R; Liu X; Zhang Z; Chen H; Xiao S
Mol Immunol; 2011 Oct; 49(1-2):407-12. PubMed ID: 21975014
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of Interferon gamma and Interleukin-21 response following foot and mouth disease virus infection.
Sharma AK; Bhatt M; Sankar M; Mohapatra JK; Dash BB; Gowane GR; Subramaniam S; Ranjan R; Pattnaik B
Microb Pathog; 2018 Dec; 125():20-25. PubMed ID: 30145254
[TBL] [Abstract][Full Text] [Related]
25. Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response.
Rodríguez Pulido M; Sáiz M
Front Cell Infect Microbiol; 2017; 7():252. PubMed ID: 28660175
[TBL] [Abstract][Full Text] [Related]
26. Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection.
Nfon CK; Toka FN; Kenney M; Pacheco JM; Golde WT
Viral Immunol; 2010 Feb; 23(1):29-41. PubMed ID: 20121400
[TBL] [Abstract][Full Text] [Related]
27. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
[TBL] [Abstract][Full Text] [Related]
28. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.
Liu H; Zhu Z; Xue Q; Yang F; Cao W; Zhang K; Liu X; Zheng H
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894473
[TBL] [Abstract][Full Text] [Related]
29. Development of Protective Immunity against Inactivated Iranian Isolate of Foot-and-Mouth Disease Virus Type O/IRN/2007 Using Gamma Ray-Irradiated Vaccine on BALB/c Mice and Guinea Pigs.
Motamedi-Sedeh F; Soleimanjahi H; Jalilian AR; Mahravani H; Shafaee K; Sotoodeh M; Taherkarami H; Jairani F
Intervirology; 2015; 58(3):190-6. PubMed ID: 26202581
[TBL] [Abstract][Full Text] [Related]
30. A Recombinant Adenovirus Expressing P12A and 3C Protein of the Type O Foot-and-Mouth Disease Virus Stimulates Systemic and Mucosal Immune Responses in Mice.
Xie Y; Gao P; Li Z
Biomed Res Int; 2016; 2016():7849203. PubMed ID: 27478836
[TBL] [Abstract][Full Text] [Related]
31. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
[TBL] [Abstract][Full Text] [Related]
32. Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.
Pega J; Di Giacomo S; Bucafusco D; Schammas JM; Malacari D; Barrionuevo F; Capozzo AV; Rodríguez LL; Borca MV; Pérez-Filgueira M
J Virol; 2015 Sep; 89(18):9581-90. PubMed ID: 26157128
[TBL] [Abstract][Full Text] [Related]
33. Interplay of foot and mouth disease virus with cell-mediated and humoral immunity of host.
Abubakar M; Manzoor S; Ahmed A
Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29282795
[TBL] [Abstract][Full Text] [Related]
34. Development of Monoclonal Antibody Specific to Foot-and-Mouth Disease Virus Type A for Serodiagnosis.
Nguyen QT; Yang J; Byun JW; Pyo HM; Park MY; Ku BK; Nah J; Ryoo S; Wee SH; Choi KS; Poo H
Pathogens; 2019 Dec; 8(4):. PubMed ID: 31861046
[TBL] [Abstract][Full Text] [Related]
35. Infection with foot-and-mouth disease virus (FMDV) induces a natural killer (NK) cell response in cattle that is lacking following vaccination.
Patch JR; Dar PA; Waters R; Toka FN; Barrera J; Schutta C; Kondabattula G; Golde WT
Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):249-57. PubMed ID: 25150134
[TBL] [Abstract][Full Text] [Related]
36. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions.
Summerfield A; Guzylack-Piriou L; Harwood L; McCullough KC
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):205-10. PubMed ID: 19026453
[TBL] [Abstract][Full Text] [Related]
37. Developing Vaccines Against Foot-and-Mouth Disease: a Biotechnological Approach.
Shahriari A; Habibi-Pirkoohi M
Arch Razi Inst; 2018 Dec; 73(1):1-10. PubMed ID: 30256033
[TBL] [Abstract][Full Text] [Related]
38. Review of the Global Distribution of Foot-and-Mouth Disease Virus from 2007 to 2014.
Brito BP; Rodriguez LL; Hammond JM; Pinto J; Perez AM
Transbound Emerg Dis; 2017 Apr; 64(2):316-332. PubMed ID: 25996568
[TBL] [Abstract][Full Text] [Related]
39. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
[TBL] [Abstract][Full Text] [Related]
40. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
